Current projections suggest approval sometime between late 2026 and early 2027
It's a melanocortin receptor agonist meaning it activates specific receptors (melanocortin receptors, specifically MC3R and MC4R) in the hypothalamus, the part of your brain that controls sexual desire, arousal, and hormonal signals
Results showed that Tirzepatide (10mg and 15mg) achieved greater weight loss than placebo at 72 weeks of treatment
Importantly, this effect has not been shown to extend to hair pigment cells
By supporting antioxidant defenses, glutathione may play a role in overall health
Disclaimer: This article is educational and is not medical, tax, or benefits advice